Clinical Trials Directory

Trials / Conditions / Multiple Endocrine Neoplasia

Multiple Endocrine Neoplasia

13 registered clinical trials studyying Multiple Endocrine Neoplasia — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingInstitutional Registry of Rare Diseases
NCT06573723
Hospital Italiano de Buenos Aires—
UnknownA Retrospective Study for Multiple Endocrine Neoplasia
NCT05812573
National Taiwan University Hospital—
CompletedThe Registry of Oncology Outcomes Associated With Testing and Treatment
NCT04028479
Taproot Health—
RecruitingMetabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
NCT03048266
M.D. Anderson Cancer Center—
UnknownVariables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine T
NCT03053999
M.D. Anderson Cancer Center—
RecruitingStudy and Follow-up of Multiple Endocrine Neoplasia Type 1
NCT03348501
Centre Hospitalier Universitaire Dijon—
RecruitingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT01793168
Sanford Health—
TerminatedA Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
NCT00947167
Pamela L. KunzPhase 2
CompletedPsychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
NCT00501449
M.D. Anderson Cancer Center—
CompletedHigh Dose Somatostatin Analogues in Neuroendocrine Tumors
NCT00990535
Federico II UniversityPhase 2
CompletedTreatment of Zollinger-Ellison Syndrome With Prevacid
NCT00204373
Charles Mel Wilcox, MDPhase 4
CompletedStudies of Elevated Parathyroid Activity
NCT00001277
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
CompletedStudies of Inherited Diseases of Metabolism
NCT00001345
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)—